Cell and Gene Therapy Tools, and Reagents: Global Markets

Cell and Gene Therapy Tools, and Reagents: Global Markets

Report Scope:

The scope of this study encompasses an investigation of the markets cell and gene therapy tools such as GMP proteins, media, cell separation and activation reagents, viral and non-viral, cytokine release syndrome monitoring products, GMP antibodies, leukapheresis instrumentation, immunoassays (multiplex and singleplex) and bioreactors. BCC Research analyzes each tool type, determines its current market status, examines its impact on future markets, and presents forecasts of growth over the next five years. Technological issues, including the latest trends, are discussed. BCC Research analyzes the industry on a worldwide basis, from both application and demand perspectives, in the major regions of the world.

Report Includes:

- 77 data tables
- An overview of the global market for immunoassay-based cell and gene therapy tools, and reagents within the life sciences industry
- Analyses of the global market trends, with data corresponding to market size for 2017-2019, and projections of compound annual growth rates (CAGRs) through 2024
- Information about in vitro diagnostics (IVD), its background and importance of IVD testing
- Discussion on prevalence of infectious disease, metabolic disorders and chronic ailments as drivers of immunoassay testing market
- Description of recent technologies such as chemiluminescent immunoassays (CLIA), fluorescent immunoassays, multiplex assays and rapid diagnostic technologies
- Evaluation of market potential for immunoassay-based cell and gene therapy tools and reagents, current market size and market forecast, and market share analysis of the leading players engaged
- Patent review and new developments, R&D efforts, industrial changes with emphasis on recent investments, and current state of the immunoassay technology
- Company profiles of the key market participants, including Bio-Rad Laboratories, Cytiva Life Sciences, Luminex Corp., Millipore Sigma, Thermo Fisher Scientific and STEMCELL Technologies


Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing this Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Evolution and Expansion of Therapies
Role for CRISPR?
New Vectors, New Solutions
Cell Therapy is Growing
Payor Policy Proves Potential
Coronavirus Crown?
Chapter 3 Market and Technology Background
Overview: Beginnings and Current State of Cell and Gene Therapy
Cell Therapy
Gene Therapy
Types of Cell and Gene Therapy
Gene Therapy
Cell Therapy
Common Equipment Used
Industry Structure
Major Companies and Market Share
Chapter 4 Market Breakdown by Region
Cell and Gene Therapy Equipment
Chapter 5 Market Breakdown by End User
Chapter 6 Government Regulations
Scope of Regulations on Gene Therapy
Viral and Non-Viral Vectors
Media
GMP Proteins and Antibodies
Cell Therapy
Leukapheresis
Cell Therapy, Gene Therapy and the EMA
Chapter 7 Patent Review/New Developments
Cell and Gene Therapy R&D
Academia
Industrial Changes
Recent Investments
Technology
Current State of Technology
Chapter 8 Analysis of Market Opportunities
Case Studies of Cell and Gene Therapy
Clinical Diagnostics
Pharmaceutical/Biotechnology
Chapter 9 Company Profiles
ABCAM
ADVERUM BIOTECHNOLOGIES
ATHERSYS INC.
AVROBIO
BIO-RAD LABORATORIES
BIO-TECHNE
CELLGENIX
CYTIVA LIFE SCIENCES
LUMINEX CORP.
MESOBLAST LTD.
MILLIPORE SIGMA
MILTENYI BIOTEC
ORGANICELL
QUANTERIX
SARTORIUS
STEMCELL TECHNOLOGIES
THERMO FISHER
List of Tables
Summary Table : Global Market for Life Science Tools, by Region, Through 2024
Table 1 : Global Market for Academic Life Science Tools, by Region, Through 2024
Table 2 : Global Market for Clinical Life Science Tools, by Region, Through 2024
Table 3 : Global Market for Biotech Life Science Tools, by Region, Through 2024
Table 4 : Global Market for GMP Proteins, by Region, Through 2024
Table 5 : Global Market for Academic GMP Proteins, by Region, Through 2024
Table 6 : Global Market for Clinical GMP Proteins, by Region, Through 2024
Table 7 : Global Market for Biotech GMP Proteins, by Region, Through 2024
Table 8 : Global Market for Media, by Region, Through 2024
Table 9 : Global Market for Academic Media, by Region, Through 2024
Table 10 : Global Market for Clinical Media, by Region, Through 2024
Table 11 : Global Market for Biotech Media, by Region, Through 2024
Table 12 : Global Market for Cell Separation, by Region, Through 2024
Table 13 : Global Market for Academic Cell Separation, by Region, Through 2024
Table 14 : Global Market for Biotech Cell Separation, by Region, Through 2024
Table 15 : Global Market for Clinical Cell Separation, by Region, Through 2024
Table 16 : Global Market for Gene Vectors, by Region, Through 2024
Table 17 : Global Market for Academic Gene Vectors, by Region, Through 2024
Table 18 : Global Market for Clinical Gene Vectors, by Region, Through 2024
Table 19 : Global Market for Biotech Gene Vectors, by Region, Through 2024
Table 20 : Global Market for Cytokine Release Syndrome Testing, by Region, Through 2024
Table 21 : Global Market for Academic Cytokine Release Syndrome Testing, by Region, Through 2024
Table 22 : Global Market for Clinical Cytokine Release Syndrome Testing, by Region, Through 2024
Table 23 : Global Market for Biotech Cytokine Release Syndrome Testing, by Region, Through 2024
Table 24 : Global Market for GMP Antibodies, by Region, Through 2024
Table 25 : Global Market for Academic GMP Antibodies, by Region, Through 2024
Table 26 : Global Market for Clinical GMP Antibodies, by Region, Through 2024
Table 27 : Global Market for Biotech GMP Antibodies, by Region, Through 2024
Table 28 : Global Market for Leukapheresis, by Region, Through 2024
Table 29 : Global Market for Academic Leukapheresis, by Region, Through 2024
Table 30 : Global Market for Biotech Leukapheresis, by Region, Through 2024
Table 31 : Global Market for Clinical Leukapheresis, by Region, Through 2024
Table 32 : Global Market for Bioreactors, by Region, Through 2024
Table 33 : Global Market for Academic Bioreactors, by Region, Through 2024
Table 34 : Global Market for Biotech Bioreactors, by Region, Through 2024
Table 35 : Global Market for Clinical Bioreactors, by Region, Through 2024
Table 36 : Global Market for Research Use-Only Immunoassays, by Region, Through 2024
Table 37 : Global Market for Academic Research Use-Only Immunoassays, by Region, Through 2024
Table 38 : Global Market for Clinical Research Use-Only Immunoassays, by Region, Through 2024
Table 39 : Global Market for Biotech Research Use-Only Immunoassays, by Region, Through 2024
Table 40 : Global Market for Research Use-Only Multiplex Immunoassays, by Region, Through 2024
Table 41 : Global Market for Academic Research-Use Only Multiplex Immunoassays, by Region, Through 2024
Table 42 : Global Market for Clinical Research Use-Only Multiplex Immunoassays, by Region, Through 2024
Table 43 : Global Market for Biotech Research Use-Only Multiplex Immunoassays, by Region, Through 2024
Table 44 : Global Market for Cancer Life Science Tools, by Region, Through 2024
Table 45 : Global Market for Blood Disorder Life Science Tools, by Region, Through 2024
Table 46 : Global Market for Life Science Tools for Other Diseases, by Region, Through 2024
Table 47 : Global Market for Cancer GMP Proteins, by Region, Through 2024
Table 48 : Global Market for Blood Disorder GMP Proteins, by Region, Through 2024
Table 49 : Global Market for GMP Proteins for Other Diseases, by Region, Through 2024
Table 50 : Global Market for Cancer Media, by Region, Through 2024
Table 51 : Global Market for Blood Disorder Media, by Region, Through 2024
Table 52 : Global Market for Media for Other Diseases, by Region, Through 2024
Table 53 : Global Market for Cancer Cell Separation, by Region, Through 2024
Table 54 : Global Market for Blood Disorder Cell Separation, by Region, Through 2024
Table 55 : Global Market for Cell Separation for Other Diseases, by Region, Through 2024
Table 56 : Global Market for Cancer Gene Vectors, by Region, Through 2024
Table 57 : Global Market for Blood Disorder Gene Vectors, by Region, Through 2024
Table 58 : Global Market for Gene Vectors for Other Diseases, by Region, Through 2024
Table 59 : Global Market for Cancer Cytokine Release Syndrome Testing, by Region, Through 2024
Table 60 : Global Market for Blood Disorder Cytokine Release Testing, by Region, Through 2024
Table 61 : Global Market for Cytokine Release Testing for Other Diseases, by Region, Through 2024
Table 62 : Global Market for Cancer GMP Antibodies, by Region, Through 2024
Table 63 : Global Market for Blood Disorder GMP Antibodies, by Region, Through 2024
Table 64 : Global Market for GMP Antibodies for Other Diseases, by Region, Through 2024
Table 65 : Global Market for Cancer Leukapheresis, by Region, Through 2024
Table 66 : Global Market for Blood Disorder Leukapheresis, by Region, Through 2024
Table 67 : Global Market for Leukapheresis for Other Diseases, by Region, Through 2024
Table 68 : Global Market for Cancer Bioreactors, by Region, Through 2024
Table 69 : Global Market for Blood Disorder Bioreactors, by Region, Through 2024
Table 70 : Global Market for Bioreactors for Other Diseases, by Region, Through 2024
Table 71 : Global Market for Cancer Immunoassays, by Region, Through 2024
Table 72 : Global Market for Blood Disorder Immunoassays, by Region, Through 2024
Table 73 : Global Market for Immunoassays for Other Diseases, by Region, Through 2024
Table 74 : Global Market for Cancer Multiplex Immunoassays, by Region, Through 2024
Table 75 : Global Market for Blood Disorder Multiplex Immunoassays, by Region, Through 2024
Table 76 : Global Market for Multiplex Immunoassays for Other Diseases, by Region, Through 2024
List of Figures
Summary Figure : Global Market for Life Science Tools, by Region, 2017-2024

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook